Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Resultados 1 - 3 de 3
Filtrar
1.
Pediatr Crit Care Med ; 13(3): e161-5, 2012 May.
Artículo en Inglés | MEDLINE | ID: mdl-22198810

RESUMEN

CONTEXT: Spinal muscular atrophy type 1, an autosomal recessive motor neuron disease, is a leading genetic cause of death in infancy and early childhood. OBJECTIVE: To determine whether the early initiation of noninvasive respiratory interventions is associated with longer survival. DESIGN: Single-institution retrospective cohort study identified children with spinal muscular atrophy type 1 from January 1, 2002 to May 1, 2009 who were followed for 2.3 mean yrs. SETTING: Tertiary care children's hospital and outpatient clinics in a vertically integrated healthcare system. PATIENTS OR OTHER PARTICIPANTS: Forty-nine children with spinal muscular atrophy type 1 were grouped according to the level of respiratory support their caregivers chose within the first 3 months after diagnosis: proactive respiratory care (n = 26) and supportive care (n = 23). INTERVENTIONS: Proactive respiratory care included bilevel noninvasive ventilation during sleep and twice a day cough assist while supportive respiratory care included suctioning, with or without supplemental oxygen. MEASUREMENTS AND MAIN RESULTS: Kaplan-Meier survival curves were assessed based on intention to treat. Children treated with early proactive respiratory support had statistically longer survival compared to supportive care (log rank 0.047); however, the adjusted hazard ratio for survival was not statistically different (2.44 [95% confidence interval 0.84-7.1]). Children in the proactive group were more likely to be hospitalized for respiratory insufficiency (83% vs. 46%) and had shortened time after diagnosis until first hospital admission for respiratory insufficiency (median 118 vs. 979 days). CONCLUSION: Longer survival time with spinal muscular atrophy type 1 is associated with early, noninvasive respiratory care interventions after diagnosis.


Asunto(s)
Cuidados Paliativos/métodos , Insuficiencia Respiratoria/terapia , Terapia Respiratoria/métodos , Atrofias Musculares Espinales de la Infancia/complicaciones , Estudios de Cohortes , Femenino , Costos de la Atención en Salud , Humanos , Lactante , Análisis de Intención de Tratar , Masculino , Cuidados Paliativos/economía , Insuficiencia Respiratoria/economía , Insuficiencia Respiratoria/etiología , Insuficiencia Respiratoria/mortalidad , Terapia Respiratoria/economía , Estudios Retrospectivos , Atrofias Musculares Espinales de la Infancia/economía , Atrofias Musculares Espinales de la Infancia/mortalidad , Análisis de Supervivencia , Resultado del Tratamiento , Utah
2.
Pediatr Emerg Care ; 27(9): 869-71, 2011 Sep.
Artículo en Inglés | MEDLINE | ID: mdl-21926889

RESUMEN

OBJECTIVE: The objective of the study was to report the toxicity of phosphine gas after a residential fumigation that resulted in fatal poisoning of a 15-month-old toddler and her 4-year-old sibling. METHODS: This is a case report and a review of literature. RESULTS: A family of 6 members was exposed to phosphine gas after their yard was treated with aluminum phosphide for a rodent infestation. The inhalation of phosphine gas initially caused symptoms of abdominal distress in all of the family members. Within 36 hours of exposure, the 4-year-old sibling died of cardiopulmonary failure in a local emergency department. After an initial presentation of respiratory distress, the 15-month-old toddler progressed to complete cardiopulmonary collapse and did not survive despite aggressive intervention including extracorporeal membrane life support. CONCLUSIONS: Unintentional phosphine gas exposure is rare but has a toxic profile that results in a high fatality rate with no known antidote.


Asunto(s)
Accidentes Domésticos , Compuestos de Aluminio/envenenamiento , Errores Diagnósticos , Paro Cardíaco/inducido químicamente , Fosfinas/envenenamiento , Rodenticidas/envenenamiento , Adulto , Niño , Preescolar , Diarrea/inducido químicamente , Urgencias Médicas , Resultado Fatal , Femenino , Enfermedades Transmitidas por los Alimentos/diagnóstico , Gases , Paro Cardíaco/terapia , Humanos , Lactante , Masculino , Náusea/inducido químicamente , Vómitos/inducido químicamente
3.
Congenit Heart Dis ; 5(5): 462-4, 2010.
Artículo en Inglés | MEDLINE | ID: mdl-21087434

RESUMEN

Alagille syndrome is a dominantly inherited multisystem disorder involving multiple organs including the liver, heart, eyes, face, and skeleton. Congenital heart defects, the majority of which are right-sided, contribute significantly to the mortality of these patients. We report a patient with Alagille syndrome who presented with mitral valve regurgitation requiring valvuloplasty and subsequent mitral valve replacement. The patient was ultimately diagnosed with anomalous origin of the left coronary artery from the pulmonary artery and underwent successful reimplantation.


Asunto(s)
Síndrome de Alagille/complicaciones , Anomalías de los Vasos Coronarios/complicaciones , Insuficiencia de la Válvula Mitral/congénito , Arteria Pulmonar/anomalías , Síndrome de Alagille/diagnóstico , Síndrome de Alagille/terapia , Cateterismo , Anomalías de los Vasos Coronarios/diagnóstico , Anomalías de los Vasos Coronarios/terapia , Femenino , Implantación de Prótesis de Válvulas Cardíacas , Humanos , Lactante , Insuficiencia de la Válvula Mitral/diagnóstico , Insuficiencia de la Válvula Mitral/terapia , Arteria Pulmonar/cirugía , Reimplantación , Resultado del Tratamiento , Procedimientos Quirúrgicos Vasculares
SELECCIÓN DE REFERENCIAS
Detalles de la búsqueda